Analgesics (Pharmacies) - Sierra Leone

  • Sierra Leone
  • Revenue in the Analgesics market is projected to reach US$6.57m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.79%, resulting in a market volume of US$10.01m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.73 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Sierra Leone has been experiencing significant growth in recent years. Customer preferences for over-the-counter pain relief medications have been a driving force behind this trend. Additionally, local special circumstances and underlying macroeconomic factors have played a role in shaping the market. Customer preferences in Sierra Leone have shifted towards analgesics purchased from pharmacies. This is due to several factors, including the convenience of accessing these medications and the trust that customers have in the quality of products sold in pharmacies. As the healthcare system in Sierra Leone continues to develop, more people are seeking professional advice and guidance when it comes to managing their pain. Pharmacies, with their knowledgeable staff and wide range of analgesic products, have become a preferred destination for customers seeking relief. Trends in the market reflect the growing demand for analgesics in Sierra Leone. The market has seen an increase in the number of pharmacies offering a variety of analgesic products, including both generic and branded options. This has led to increased competition among pharmacies, driving innovation in product offerings and pricing strategies. Additionally, there has been a shift towards the use of natural and herbal remedies, as customers become more conscious of the potential side effects of traditional analgesics. Local special circumstances in Sierra Leone have also contributed to the development of the Analgesics (Pharmacies) market. The country has a high prevalence of infectious diseases, such as malaria and typhoid fever, which can cause pain and discomfort. This has created a need for effective pain relief medications, leading to increased demand for analgesics. Additionally, Sierra Leone has a young and growing population, which has contributed to the overall increase in healthcare consumption, including the use of analgesics. Underlying macroeconomic factors have also played a role in shaping the Analgesics (Pharmacies) market in Sierra Leone. The country has experienced steady economic growth in recent years, leading to an increase in disposable income and improved access to healthcare services. This has allowed more people to afford and access analgesics from pharmacies. Furthermore, the government has implemented policies to improve healthcare infrastructure and increase access to essential medications, which has further fueled the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Sierra Leone has experienced significant growth due to customer preferences, local special circumstances, and underlying macroeconomic factors. With the increasing demand for pain relief medications and the development of the healthcare system, the market is expected to continue to expand in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)